24 completed, 5 unknown, 4 not yet recruiting, 3 terminated. 5 Not applicable, 4 Phase 2, 4 Phase 3, 3 Phase 1, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Unknown 1 |
| Phase 2 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 3 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 4 | 2 | Completed 2 |
Follow Disseminated Intravascular Coagulation: new trials by email Literature Review of Disseminated Intravascular Coagulation trials Research Report on Disseminated Intravascular Coagulation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EARLY DIAGNOSIS OF SEPTIC DIC Disseminated Intravascular Coagulation (DIC), Reanimation | Not yet recruiting | University Hospital, Strasbourg, France | 492 | 2026-06-15 | 2026-06-05 | |
| Fluorescent Leukocytes as a Marker of Early Sepsis/Severity Sepsis, Disseminated Intravascular Coagulation (DIC) | Not yet recruiting | University Hospital, Strasbourg, France | 492 | 2026-05-12 | 2026-05-14 | |
| Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy An additional volume of blood will be drawn as part of routine follow-up care - Hematologic Neoplasms, Solid Tumor Metastatic Cancer Advanced Cancer | Not yet recruiting | University Hospital, Strasbourg, France | 150 | 2026-01-01 | 2025-12-10 | |
| A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers. BAY 3389934, Matching Placebo / Diluent - Sepsis Associated Disseminated Intravascular Coagulation (DIC) | Phase 1 | Completed | Bayer | 16 | 2025-09-22 | 2026-06-05 |
| A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy BAY3389934 - Sepsis, Coagulopathy | Phase 1 | Recruiting | Bayer | 36 | 2025-03-12 | 2026-10-16 |
| An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related Diagnosis of both VTE and sepsis - Sepsis, Venous Thromboembolism | Active not recruiting | Bayer | 10000 | 2025-01-06 | 2026-10-19 | |
| Predictive Value of Scoring System in Neonates with Disseminated Intravascular Coagulation Disseminated Intravascular Coagulation, Neonates | Not yet recruiting | Assiut University | 43 | 2025-01-01 | 2024-10-04 | |
| Longitudinal Cohort of Thrombosis and Hemostasis Diseases Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura | Recruiting | Peking University People's Hospital | 3000 | 2024-11-01 | 2024-12-11 | |
| Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients Septic Shock, Disseminated Intravascular Coagulation | Completed | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 60 | 2024-04-12 | 2026-07-28 | |
| An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan No study intervention - Sepsis, Disseminated Intravascular Coagulation | Completed | Bayer | 5740 | 2024-03-22 | 2026-01-21 | |
| The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation no intervention - Disseminated Intravascular Coagulation | Unknown | Qilu Hospital of Shandong University | 462 | 2022-12-01 | 2023-10-24 | |
| Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery Fibrinogen Concentrate Human - Fibrinogen, Spine Deformity | Phase 4 | Completed | Brno University Hospital | 32 | 2022-06-06 | 2026-10-16 |
| Hemostatic Variables In Snakebite Study Snake Bites, Coagulopathy, Consumption | Completed | Jubilee Mission Medical College and Research Institute | 96 | 2022-03-15 | 2024-03-07 | |
| Waveform Analysis In Snakebite Victims With Hematotoxicity Snakebite, Coagulopathy, Consumption | Completed | Jubilee Mission Medical College and Research Institute | 96 | 2022-03-01 | 2023-07-17 | |
| Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients Nusapure standardized olive leaves capsule, 750 mg (50% oleuropein) - Covid19, COVID-19 Respiratory Infection | Not applicable | Completed | Shimaa M. Abdelgawad | 60 | 2021-05-10 | 2023-02-08 |
| Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC 5-fluorouracil, Docetaxel - Gastric Cancer, Bone Marrow Metastasis | Phase 2 | Completed | Sixth Affiliated Hospital, Sun Yat-sen University | 24 | 2021-01-15 | 2024-03-25 |
| Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults cAd3-Marburg, cAd3-EBO-S - Ebola Virus Disease, Marburg Virus Disease | Phase 1 | Completed | Albert B. Sabin Vaccine Institute | 32 | 2021-01-06 | 2022-08-03 |
| Rotational Thromboelastometry Versus DIC Score in Sepsis rotational thromboelastometry - Sepsis, Septic Shock | Completed | University of Leipzig | 100 | 2020-11-02 | 2024-12-20 | |
| Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study OctaplasLG®, 0.9% NaCl - Septic Shock, Coagulopathy | Not applicable | Completed | University Hospital, Strasbourg, France | 60 | 2020-10-22 | 2026-03-16 |
| Coagulation Changes Associated With COVID-19 Infection Quantra System - COVID, Disseminated Intravascular Coagulation | Completed | HemoSonics LLC | 15 | 2020-08-14 | 2022-05-13 |
Showing 20 of 40. Sign in to see all of them.
Sepsis (13) · Hemostatic Disorders (9) · Shock, Septic (8) · COVID-19 (5) · Thrombosis (4) · Snake Bites (3) · Blood Coagulation Disorders (2) · Critical Illness (2) · Hemorrhage (2) · Venous Thrombosis (2) · Acquired Immunodeficiency Syndrome (1) · Acquired angioedema (1) · Angioedemas, Hereditary (1) · Arrhythmias, Cardiac (1)
Hematologic Diseases (40) · Hemic and Lymphatic Diseases (40) · Hemorrhagic Disorders (40) · Thrombophilia (39) · Blood Coagulation Disorders (38) · Pathological Conditions, Signs and Symptoms (24) · Pathologic Processes (23) · Infections (20) · Inflammation (17) · Systemic Inflammatory Response Syndrome (17) · Cardiovascular Diseases (15) · Vascular Diseases (15) · Shock (9) · Embolism and Thrombosis (6) · Lung Diseases (6)
ART123 (2) · Fibrinogen (2) · Saline Solution (2) · Aspirin (1) · Blood Coagulation Tests (1) · Blood Specimen Collection (1) · Docetaxel (1) · Erythrocyte Count (1) · Fluorouracil (1) · Fumigant 93 (1) · Heparin (1) · Platelet Count (1) · Sodium Chloride (1) · Thrombelastography (1) · Vitamin D (1)
Bayer (4) · University Hospital, Strasbourg, France (4) · Kyowa Kirin Co., Ltd. (3) · Assiut University (2) · Jubilee Mission Medical College and Research Institute (2) · Albert B. Sabin Vaccine Institute (1) · Angel Augusto Perez Calatayud (1) · Artisan Pharma, Inc. (1) · Asahi Kasei Therapeutics Corporation (1) · Brno University Hospital (1) · Centre Hospitalier Universitaire de Nīmes (1) · China Medical University, China (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Hallym University Medical Center (1) · Hansung University (1)
France (6) · Japan (6) · United States (6) · China (5) · India (3) · Belgium (2) · Egypt (2) · Germany (2) · Netherlands (2) · Australia (1) · Austria (1) · Canada (1) · Czechia (1) · Italy (1) · Malaysia (1)
Angel Augusto Perez Calatayud, M.D. (1) · Christophe Beauloye, MD (1) · David Hoover, MD (1) · Deborah L. Brown, M.D. (1) · Dinesh Chandra, MD, DM (1) · Frank H Lau, MD (1) · Jean-Christophe Gris (1) · Jecko Tachil, MD PhD (1) · Jian Xiao, MD (1) · Marcello Di Nisio, MD PhD (1) · Miao Xu (1) · Michael Stevenson, MD (1) · Mohan Gurjar, MD, PDCC (1)
PMID 1538192, PMID 15577929, PMID 16375711, PMID 24588439, PMID 25426834, PMID 25655210, PMID 26591047, PMID 27832552, PMID 28082026, PMID 28264702, PMID 29084499, PMID 29198832, PMID 30429630, PMID 30473794, PMID 36346044, PMID 36608393, PMID 37236666, PMID 37489818, PMID 38167115, PMID 40826421, PMID 41062134, PMID 8237108
2019 (1)